Table 3.
SUVmax | % agreement | Kappa | P-value | ||||
---|---|---|---|---|---|---|---|
SUVpeak | PR | SD | PD | Total SUVpeak |
86% | 0.77 | <0.001 |
PR | 22 | 3 | 0 | 25 | |||
SD | 0 | 12 | 2 | 14 | |||
PD | 0 | 2 | 8 | 10 | |||
Total SUVmax | 22 | 17 | 10 | ||||
MTV | Total MTV | ||||||
PR | 17 | 2 | 4 | 23 | 55% | 0.30 | 0.002 |
SD | 1 | 9 | 5 | 15 | |||
PD | 4 | 6 | 1 | 11 | |||
TLG | Total TLG | ||||||
PR | 18 | 3 | 1 | 22 | 59% | 0.36 | <0.001 |
SD | 3 | 8 | 6 | 17 | |||
PD | 1 | 6 | 3 | 10 | |||
SUVpeak | % agreement | Kappa | P-value | ||||
MTV | PR | SD | PD | 51% | 0.22 | 0.02 | |
PR | 17 | 2 | 4 | ||||
SD | 3 | 7 | 5 | ||||
PD | 5 | 5 | 1 | ||||
TLG | |||||||
PR | 19 | 2 | 1 | 63% | 0.42 | <0.001 | |
SD | 4 | 8 | 5 | ||||
PD | 2 | 4 | 4 | ||||
MTV | % agreement | Kappa | P-value | ||||
TLG | PR | SD | PD | 75% | 0.62 | <0.001 | |
PR | 20 | 2 | 0 | ||||
SD | 3 | 10 | 4 | ||||
PD | 0 | 3 | 7 |
PR: Partial Response
SD: Stable Disease
PD: Progression of Disease